Rothschild Investment LLC Sells 268 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Rothschild Investment LLC lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,284 shares of the company’s stock after selling 268 shares during the quarter. Rothschild Investment LLC’s holdings in GE HealthCare Technologies were worth $179,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC raised its holdings in GE HealthCare Technologies by 2.3% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock worth $2,317,000 after purchasing an additional 562 shares during the last quarter. Assenagon Asset Management S.A. grew its position in shares of GE HealthCare Technologies by 10.1% during the 3rd quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company’s stock worth $1,289,000 after buying an additional 1,256 shares during the period. Dakota Wealth Management acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $210,000. Modera Wealth Management LLC grew its position in shares of GE HealthCare Technologies by 64.6% during the 3rd quarter. Modera Wealth Management LLC now owns 7,146 shares of the company’s stock worth $671,000 after buying an additional 2,804 shares during the period. Finally, Frank Rimerman Advisors LLC grew its position in shares of GE HealthCare Technologies by 7.2% during the 3rd quarter. Frank Rimerman Advisors LLC now owns 3,225 shares of the company’s stock worth $303,000 after buying an additional 216 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $90.81 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock’s fifty day simple moving average is $85.49 and its two-hundred day simple moving average is $86.01. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The stock has a market cap of $41.53 billion, a PE ratio of 20.97, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.